glp-1 and marijuana Medications Get at the Heart of Addiction: Study South Dakota Medical Cannabis Program

It appears that some GLP-1 receptor agonists have a central brain effect and may be anti-inflammatory or stimulate brain recovery. What does this mean for the future of mental health treatment

& Kent, L

Semaglutide can also improve heart failure-related symptoms and inflammation in patients with obesity-related heart failure with preserved ejection fraction (HFpEP), and decrease the risk of major kidney disease events and cardiovascular-related mortality in patients with type 2 diabetes and chronic kidney disease(Butler et al 2024

Lilly recently reported topline results from the ATTAIN-1 phase-3 trial evaluating orforglipron, a once-daily oral glucagon-like-peptide-1 (GLP-1) receptor agonist for adults with obesity or overweight without diabetes